The obesity paradox: body mass index and outcomes in patients with heart failure.

[1]  O. Febo,et al.  Is nutritional intake adequate in chronic heart failure patients? , 2003, Journal of the American College of Cardiology.

[2]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[3]  Andrew J S Coats,et al.  Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. , 2003, Journal of cardiac failure.

[4]  Abdullah Al Mamun,et al.  Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis , 2003, Annals of Internal Medicine.

[5]  C. Lavie,et al.  Body composition and prognosis in chronic systolic heart failure: the obesity paradox. , 2002, The American journal of cardiology.

[6]  D. Levy,et al.  Obesity and the risk of heart failure. , 2003, The New England journal of medicine.

[7]  S A Stansfeld,et al.  Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study , 2002, Circulation.

[8]  Tracey McLaughlin,et al.  Relationship between obesity, insulin resistance, and coronary heart disease risk. , 2002, Journal of the American College of Cardiology.

[9]  S. Anker,et al.  The syndrome of cardiac cachexia. , 2002, International journal of cardiology.

[10]  V. Froelicher,et al.  The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. , 2002, Journal of cardiac failure.

[11]  G. Schuler,et al.  Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. , 2002, Journal of the American College of Cardiology.

[12]  H. Gurm,et al.  The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). , 2002, Journal of the American College of Cardiology.

[13]  P. Elwood,et al.  Height, body mass index, and survival in men with coronary disease: follow up of the diet and reinfarction trial (DART) , 2002, Journal of epidemiology and community health.

[14]  N. Weissman,et al.  The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? , 2002, Journal of the American College of Cardiology.

[15]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[16]  G. Fonarow,et al.  The relationship between obesity and mortality in patients with heart failure. , 2001, Journal of the American College of Cardiology.

[17]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[18]  A Hofman,et al.  The prognosis of heart failure in the general population: The Rotterdam Study. , 2001, European heart journal.

[19]  Anita Deswal,et al.  Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) , 2001, Circulation.

[20]  S. Anker,et al.  Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.

[21]  C. Lavie,et al.  The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. , 2000, Journal of the American College of Cardiology.

[22]  S. Yusuf,et al.  HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America. , 2000, Pharmacotherapy.

[23]  S. Dunlap,et al.  Association of body mass, gender and race with heart failure primarily due to hypertension. , 1999, Journal of the American College of Cardiology.

[24]  M. Thun,et al.  Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.

[25]  P Royston,et al.  The use of fractional polynomials to model continuous risk variables in epidemiology. , 1999, International journal of epidemiology.

[26]  J. Bower,et al.  Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. , 1999, Kidney international.

[27]  Marvin A. Konstam,et al.  Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. , 1999, Journal of cardiac failure.

[28]  P. Poole‐Wilson,et al.  Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. , 1998, Journal of the American College of Cardiology.

[29]  H. Volk,et al.  Systemic inflammation in patients with heart failure. , 1998, European heart journal.

[30]  D. Siscovick,et al.  Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. , 1998, American journal of public health.

[31]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[32]  P. Poole‐Wilson,et al.  Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. , 1997, The American journal of cardiology.

[33]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[34]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[35]  S. Ellis,et al.  Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. , 1996, The American journal of cardiology.

[36]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[37]  D. M. Barr,et al.  Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. , 1996, Controlled clinical trials.

[38]  D. Mann,et al.  Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. , 1996, Circulation.

[39]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[40]  R. Roubenoff,et al.  The nutrition implications of cardiac cachexia. , 2009, Nutrition reviews.

[41]  D. Mann,et al.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.

[42]  G. Morris,et al.  Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.

[43]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.